THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA

Background. Thrombosis and hemorrhage are the main category of complications, that affects the overall survival (OS), quality of life and therapy option choice in essential thrombocythemia (ET). Molecular marker presence (JAK2V617F (JAK2+), MPL (MPL+), CALR (CALR1+-type 1, CALR2+-type 2) or its abse...

Full description

Bibliographic Details
Main Authors: A. A. Zhernyakova, I. S. Martynkevich, V. A. Shuvaev, L. B. Polushkina, M. S. Fominykh, V. Yu. Udal’eva, I. I. Zotova, D. I. Shiсhbabaeva, S. V. Voloshin, S. S. Бессмельцев, A. V. Chechetkin, K. M. Abdulkadyrov
Format: Article
Language:Russian
Published: ABV-press 2017-06-01
Series:Онкогематология
Subjects:
essential thrombocythemia
janus kinase gene mutation (jak2v617f)
calreticulin gene mutation
myeloproliferative leukemia virus oncogene
triple-negative status
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/239

Internet

https://oncohematology.abvpress.ru/ongm/article/view/239

Similar Items